John Libbey Eurotext

Magnesium Research

MENU

Magnesium citrate supplementation decreased blood pressure and HbA1c in normomagnesemic subjects with metabolic syndrome: a 12-week, placebo-controlled, double-blinded pilot trial Volume 34, issue 3, July-August-September 2021

  • [1] Huang P.L. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2:231-237.
  • [2] Katsimardou A., Imprialos K., Stavropoulos K., Sachinidis A., Doumas M., Athyros V. Hypertension in metabolic syndrome: novel insights. Curr Hypertens Rev. 2020;16:12-18.
  • [3] Guerrero-Romero F., Rodríguez-Morán M. Hypomagnesemia, oxidative stress, inflammation and metabolic syndrome. Diabetes Metab Res Rev. 2006;22:471-476.
  • [4] Samson S.L., Garber A.J. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014;43:1-23.
  • [5] Saklayen M.G. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20:12.
  • [6] Mottillo S., Filion K.B., Genest J. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113-1132.
  • [7] Zheng Y., Xie Z., Li J. Meta-analysis of metabolic syndrome and its individual components with risk of atrial fibrillation in different populations. BMC Cardiovasc Disord. 2021;21:90.
  • [8] Xu J.J., Song Y., Jiang P. Effects of metabolic syndrome on onset age and long-term outcomes in patients with acute coronary syndrome. World J Emerg Med. 2021;12:36-41.
  • [9] Esposito K., Chiodini P., Colao A., Lenzi A., Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012;35:2402-2411.
  • [10] Ford E.S., Schulze M.B., Pischon T., Bergmann M.M., Joost H.G., Boeing H. Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study. Cardiovasc Diabetol. 2008;7:35.
  • [11] Barbagallo M., Dominguez L.J. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys. 2007;458:40-47.
  • [12] Gunther T. The biochemical function of Mg(2)+ in insulin secretion, insulin signal transduction and insulin resistance. Magnes Res. 2010;23:5-18.
  • [13] Hruby A., Meigs J.B., O’Donnell C.J., Jacques P.F., McKeown N.M. Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged Americans. Diabetes Care. 2014;37:419-427.
  • [14] Grober U., Schmidt J., Kisters K. Magnesium in prevention and therapy. Nutrients. 2015;7:8199-8226.
  • [15] La S.A., Lee J.Y., Kim D.H., Song E.L., Park J.H., Ju S.Y. Low magnesium levels in adults with metabolic syndrome: a meta-analysis. Biol Trace Elem Res. 2016;170:33-42.
  • [16] Ghasemi A., Zahediasl S., Syedmoradi L., Azizi F. Low serum magnesium levels in elderly subjects with metabolic syndrome. Biol Trace Elem Res. 2010;136:18-25.
  • [17] Wang J., Persuitte G., Olendzki B.C. Dietary magnesium intake improves insulin resistance among non-diabetic individuals with metabolic syndrome participating in a dietary trial. Nutrients. 2013;5:3910-3919.
  • [18] Song Y., Ridker P.M., Manson J.E., Cook N.R., Buring J.E., Liu S. Magnesium intake, C-reactive protein and the prevalence of metabolic syndrome in middle-aged and older U. S. women. Diabetes Care. 2005;28:1438-1444.
  • [19] He K., Liu K., Daviglus M.L. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation. 2006;113:1675-1682.
  • [20] Ford E.S., Li C., McGuire L.C., Mokdad A.H., Liu S. Intake of dietary magnesium and the prevalence of the metabolic syndrome among U.S. adults. Obesity (Silver Spring). 2007;15:1139-1146.
  • [21] Dibaba D.T., Xun P., Fly A.D., Yokota K., He K. Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis. Diabet Med. 2014;31:1301-1309.
  • [22] Rodriguez-Moran M., Guerrero-Romero F. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial. Arch Med Res. 2014;45:388-393.
  • [23] Rodríguez-Morán M., Simental-Mendía L.E., Gamboa-Gómez C.I., Guerrero-Romero F. Oral magnesium supplementation and metabolic syndrome: a randomized double-blind placebo-controlled clinical trial. Adv Chronic Kidney Dis. 2018;25:261-266.
  • [24] Lima de Souza E.S.M.L., Cruz T., Rodrigues L.E. Magnesium replacement does not improve insulin resistance in patients with metabolic syndrome: a 12-week randomized double-blind study. J Clin Med Res. 2014;6:456-462.
  • [25] Guerrero-Romero F., Jaquez-Chairez F.O., Rodriguez-Moran M. Magnesium in metabolic syndrome: a review based on randomized, double-blind clinical trials. Magnes Res. 2016;29:146-153.
  • [26] Werner T., Kolisek M., Vormann J. Assessment of bioavailability of Mg from Mg citrate and Mg oxide by measuring urinary excretion in Mg-saturated subjects. Magnes Res. 2019;32:63-71.
  • [27] Chobanian A.V., Bakris G.L., Black H.R. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
  • [28] Risco F., Traba M.L. Influence of magnesium on the synthesis of 24,25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3. Magnes Res. 1992;5:5-14. in vitro
  • [29] Risco F., Traba M.L. Possible involvement of a magnesium dependent mitochondrial alkaline phosphatase in the regulation of the 25-hydroxyvitamin D3-1 alpha-and 25-hydroxyvitamin D3-24R-hydroxylases in LLC-PK1 cells. Magnes Res. 1994;7:169-178.
  • [30] Kisters K., Kisters L., Werner T., Deutsch A., Westhoff T., Grober U. Increased serum vitamin D concentration under oral magnesium therapy in elderly hypertensives. Magnes Res. 2021;33:131-132.
  • [31] Vázquez-Lorente H., Herrera-Quintana L., Molina-López J. Response of vitamin D after magnesium intervention in a postmenopausal population from the province of Granada, Spain. Nutrients. 2020;12:2283.
  • [32] Dai Q., Zhu X., Manson J.E. Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial. Am J Clin Nutr. 2018;108:1249-1258.
  • [33] Jahnen-Dechent W., Ketteler M. Magnesium basics. Clin Kidney J. 2012;5:i3-i14.
  • [34] Bertinato J., Wang K.C., Hayward S. Serum magnesium concentrations in the Canadian population and associations with diabetes, glycemic regulation and insulin resistance. Nutrients. 2017;9:296.
  • [35] ELDerawi W.A., Naser I.A., Taleb M.H., Abutair A.S. The effects of oral magnesium supplementation on glycemic response among type 2 diabetes patients. Nutrients. 2018;11:44.
  • [36] Morais J.B.S., Severo J.S., de Alencar G.R.R. Effect of magnesium supplementation on insulin resistance in humans: a systematic review. Nutrition. 2017;38:54-60.
  • [37] Mooren F.C., Kruger K., Volker K., Golf S.W., Wadepuhl M., Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab. 2011;13:281-284.
  • [38] Lee S., Park H.K., Son S.P., Lee C.W., Kim I.J., Kim H.J. Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults. Nutr Metab Cardiovasc Dis. 2009;19:781-788.
  • [39] Cosaro E., Bonafini S., Montagnana M. Effects of magnesium supplements on blood pressure, endothelial function and metabolic parameters in healthy young men with a family history of metabolic syndrome. Nutr Metab Cardiovasc Dis. 2014;24:1213-1220.
  • [40] Simental-Mendia L.E., Sahebkar A., Rodriguez-Moran M., Guerrero-Romero F. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res. 2016;111:272-282.
  • [41] Williams B., Mancia G., Spiering W. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021-3104.
  • [42] Han H., Fang X., Wei X. Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies. Nutr J. 2017;16:26.
  • [43] Sontia B., Touyz R.M. Magnesium transport in hypertension. Pathophysiology. 2007;14:205-211.
  • [44] de Baaij J.H., Hoenderop J.G., Bindels R.J. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95:1-46.
  • [45] Zhang X., Li Y., Del Gobbo L.C. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension. 2016;68:324-333.
  • [46] Kass L., Weekes J., Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr. 2012;66:411-418.
  • [47] Jee S.H., Miller ER 3rd, Guallar E., Singh V.K., Appel L.J., Klag M.J. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens. 2002;15:691-696.
  • [48] Dibaba D.T., Xun P., Song Y., Rosanoff A., Shechter M., He K. The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2017;106:921-929.
  • [49] Rosanoff A., Plesset M.R. Oral magnesium supplements decrease high blood pressure (SBP>155 mmHg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis. Magnes Res. 2013;26:93-99.
  • [50] Kisters K. Oral magnesium supplementation improves borderline hypertension. Magnes Res. 2011;24:17.
  • [51] Flint A.C., Conell C., Ren X. Effect of systolic and diastolic blood pressure on cardiovascular outcomes. N Engl J Med. 2019;381:243-251.